PMC:4159490 / 15944-17246 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4159490","sourcedb":"PMC","sourceid":"4159490","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4159490","text":"Seventy-six MHD patients and 40 normal controls were recruited and studied. Five participants were excluded because of prosthetic leg (one MHD patient) or not wearing the activity monitor for at least 7 days (three MHD patients, one normal). We obtained sufficient data for analysis on 72 MHD patients and 39 normal controls. Their characteristics are shown in Table 1. MHD patients and normal controls were 52.3 ± 12.9 (SD) (range, 24–85), and 51.0 ± 12.7 (range, 20–75) years old, respectively. Dialysis vintage was 53.9 ± 45.0 months. Only 31.6 % of the MHD patients had diabetes mellitus, which may reflect the fact that the inclusion/exclusion criteria selected a healthier subset of MHD patients and, hence, a disproportionately large number of diabetic patients were excluded from the study. There were no significant differences between MHD patients and normals with regard to age, weight, gender distribution, educational level, and racial/ethnic distribution. MHD patients and normals each had normal serum albumin levels, averaging 4.1 g/dL. Fat-free, edema-free (lean) body mass, and percent body fat were not different, and their BMI averaged in the overweight range (Table 1). The Charlson Comorbidity Index in the MHD patients averaged 5.7 ± 2.7 (median value, 5; range of values, 2–13).","tracks":[]}